Despite our best efforts, diseases of the brain are on the rise. Neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases threaten not only to devastate our aging population, but also cripple our economy. Meanwhile, the causes of conditions such as autism remain largely unknown. And brain and spinal cord injuries continue to increase—leaving their victims … Continue reading Bringing out the Big Guns: Scientists Weigh in on How Best to Combat Deadly Diseases of the Brain
clinical trials
Stem Cell Stories that Caught our Eye: Perspective on “Walking” Patient, Blood Stem Cells have a Helper and Three Clinical Trials at One Campus
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Some perspective on nasal stem cells and ”walking” patient. PZ Meyers writing on ScienceBlogs did a good job of putting some perspective into the hype … Continue reading Stem Cell Stories that Caught our Eye: Perspective on “Walking” Patient, Blood Stem Cells have a Helper and Three Clinical Trials at One Campus
Policy Matters: Stem Cells and the Public Interest
Guest Author Geoff Lomax is CIRM’s Senior Officer for Medical and Ethical Standards. In the spirit of Stem Cell Awareness Day, Cell Stem Cell has compiled a “Public Interest” collection of articles covering ethical, legal, and social implications of stem cell research and made it freely available. The collection may be found here. The collection … Continue reading Policy Matters: Stem Cells and the Public Interest
See You Next Week: 2014 Stem Cell Meeting on the Mesa
Next week marks the fourth annual Stem Cell Meeting on the Mesa (SCMOM) Partnering Forum in La Jolla, California and CIRM , one of the main organizers, hopes to see you there. SCMOM is the first and only meeting organized specifically for the regenerative medicine and cell therapy sectors. The meeting’s unique Partnering Forum brings … Continue reading See You Next Week: 2014 Stem Cell Meeting on the Mesa
FDA gives Asterias green light to start CIRM-funded clinical trial in spinal cord injury
This morning Asterias Biotherapeutics announced that they have been cleared by the Food and Drug Administration (FDA) to start a clinical trial using stem cells to treat spinal cord injury. It’s great news, doubly so as we are funding that trial. You can read more about the trial in a news release we just sent … Continue reading FDA gives Asterias green light to start CIRM-funded clinical trial in spinal cord injury
International Stem Cell Conference Opens with Public Quest to Sort the Real from the Bogus
While the scientific sessions of the International Society for Stem Cell Research don’t begin until this morning, the meeting started last night with one of its most important events: a panel discussion for patient advocates and other members of the public. After presentations by the five speakers it became clear that the dichotomy between real … Continue reading International Stem Cell Conference Opens with Public Quest to Sort the Real from the Bogus
The Stem Cellar 